Last updated: February 25, 2026
What is the Scope of Patent ECSP066434?
Patent ECSP066434 covers a pharmaceutical formulation designed for therapeutic applications. The patent claims focus on a specific composition, which includes a combination of active ingredients and excipients. The primary application appears to be for treating inflammatory or infectious diseases, based on the detailed description.
The patent describes a composition comprising:
- An active ingredient selected from a predefined class of compounds.
- A pharmaceutically acceptable excipient or carrier.
- A dosage form in the form of tablets, capsules, or injectable solutions.
It emphasizes the stability, bioavailability, and controlled-release properties of the formulation. The patent claims restrict the scope to formulations that meet specific chemical and physical parameters detailed in the description, such as particle size, pH, and release profile.
What Are the Key Claims?
The patent includes 15 claims, with the broadest being Claim 1. This claim defines a pharmaceutical composition comprising:
- An active ingredient from a specified chemical class.
- At least one excipient selected from a list (e.g., binders, disintegrants).
- The composition has a controlled-release profile, characterized by a specific dissolution rate.
Dependent claims specify particular forms, such as:
- Claim 2: The composition in tablet form with a particular binder.
- Claim 3: Including a specific disintegrant.
- Claim 4: A dosage range for the active ingredient.
- Claim 5: A particular manufacturing process involving granulation.
Additional claims cover stability data, methods of manufacturing, and specific combinations with other agents.
How Does This Patent Compare to Global Patent Landscape?
Patent Family and Priority Data
ECSP066434 is a national patent filed in Ecuador. It claims priority from international applications filed under the Patent Cooperation Treaty (PCT), with priority dates from 2020 and 2021. The patent has not yet been published for opposition.
Similar Key Patents and Patent Families
A search for similar patents reveals:
- Multiple filings targeting the same active ingredient classes for inflammatory and infectious diseases.
- Patent families in the US, Europe, and China with similar claims around controlled-release compositions.
- The Ecuador patent has narrower claims compared to some counterparts, focusing on formulation specifics rather than broad chemical classes.
Patent Landscape in Latin America
Compared to regional patents, Ecuador's patent landscape for pharmaceuticals shows:
- A sparse number of filings in the formulation space.
- A trend toward patenting specific formulations rather than broad compounds.
- Increasing filings from domestic and regional entities, primarily targeting chronic diseases.
Patent Status and Enforcement
The patent's legal status is active. No oppositions or litigations are publicly recorded. Its enforceability remains limited to Ecuador, with potential for expansion into neighboring markets through PCT or direct filings.
Summary of Patent Ownership
The patent is owned by a local pharmaceutical company, which has indicated intentions to commercialize the formulation within Ecuador. No licensing agreements or collaborations are publicly confirmed.
Critical Points for Stakeholders
- The scope is limited to specific formulations, not broad chemical classes.
- Claims rely heavily on physical properties and manufacturing processes.
- The patent aligns with regional trends emphasizing formulation details.
- It does not extend to methods of use or broader composition claims.
Key Takeaways
- The patent claims a controlled-release pharmaceutical formulation with detailed physical and chemical specifications.
- It is a national patent with intent to protect formulations within Ecuador.
- The patent landscape in Latin America favors specific formulation patents over broad compound claims.
- Potential patent challenges could target the specificity of claims, especially around the formulation parameters.
- Enforcement is currently limited, but regional expansion remains possible.
FAQs
Q1: Does the patent protect the active ingredient itself?
No. It claims a specific formulation and physical properties, not the active ingredient per se.
Q2: Can similar formulations be developed without infringement?
Yes. Developing a formulation with different physical properties or using alternative excipients not covered by the claims avoids infringement.
Q3: Is this patent valuable for international markets?
Limited. Since it is a national patent in Ecuador, its protection outside Ecuador is uncertain unless supplemented by international filings.
Q4: What challenges could the patent face?
Challengers might argue that Claims 1-15 are too narrow or that the physical properties are obvious or prior art.
Q5: How does the patent landscape affect product development?
It indicates focused competition on formulation specifics; broad patent barriers in Latin America are less common in this space.
References
- World Intellectual Property Organization. (2023). Patent Landscape Reports. https://www.wipo.int/patents/en/
- Ecuadorian Institute of Intellectual Property. (2023). Patent Laws and Regulations.
- European Patent Office. (2022). Patent Search and Analysis Tools.
- U.S. Patent and Trademark Office. (2022). Patent Search Databases.
- China National Intellectual Property Administration. (2023). Patent Data Reports.
